NICE quality standard for attention deficit hyperactivity disorder (QS39)

Similar documents
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE. Personality Disorder: the clinical management of borderline personality disorder

METHYLPHENIDATE AND ATOMOXETINE TREATMENT OF ATTENTION DEFICIT HYPERACTIVITY DISORDER IN CHILDREN AND YOUNG PEOPLE

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE

Professor Tim Kendall

Diagnosis and management of ADHD in children, young people and adults

Psychosis & Schizophrenia: The Updated NICE Quality Standard. Dr Tony Gill Mental Health Practitioner University of Leeds 7 th June 2015

Adult ADHD: How Big is the Problem? Delivering Effective Services for Adults with ADHD

Attention deficit hyperactivity disorder

Methylphenidate Shared Care Agreement For attention deficit hyperactivity disorder (ADHD) in adults Effective Shared Care Agreement

HERTFORDSHIRE PARTNERSHIP UNIVERSITY NHS FOUNDATION TRUST. Referral Criteria for Specialist Tier 3 CAMHS

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE

Attention Deficit Hyperactivity Disorder (ADHD) in adults Patient information leaflet

NICE Quality Standards and commissioning dementia care

Adult ADHD for GPs. Maria Mazfari Associate Nurse Consultant Adult ADHD Tina Profitt Clinical Nurse Specialist Adult ADHD

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE Scope for Partial Update

Attention Deficit Hyperactivity Disorder

Adult Neurodevelopmental Services. ADHD Shared Protocol

Project Initiation Document:

The identification and management of heterozygous familial hypercholesterolaemia in adults, young people and children (QS41)

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:

Dr S H Jawed Consultant General Adult Psychiatrist, Dorothy Pattison Hospital, Walsall Joint Lead Consultant for

To approve Primary Care Commissioning Committees in Common Date: 9/11/18. NWS CCG 58 Church St, Weybridge, Surrey, KT13 8DP

Attention Deficit Hyperactive Disorder (ADHD)

Service Specification: Bristol and South Gloucestershire Specialist Substance Misuse Treatment Service January 2016

Kent Joint Commissioning Action Plan For Adults with Autism and or ADHD (2017 / 2021)

Nikki Mallinder on behalf of Linda Honey. Karen Thorburn Date: 04/10/18

Accessibility and Disability Service. A Guide to Services for Students with

Diagnosis and management of ADHD in children and adults

Clinical guideline Published: 24 September 2008 nice.org.uk/guidance/cg72

Worcestershire's Autism Strategy

Outline & Objectives

AUTISM STRATEGY FOR ADULTS IN BIRMINGHAM

NICE Medicines Guidance

SHARED CARE PROTOCOL FOR THE PRESCRIBING AND MONITORING OF MEDICINES FOR ATTENTION-DEFICIT HYPERACTIVITY DISORDER (ADHD)

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE Centre for Clinical Practice SCOPE

Guideline scope Persistent pain: assessment and management

Issue date September 2010 (Reviewed October 2013) Clinicians from Andrew Lang Centre, Mental. Specialist Pharmacist & Formulary Pharmacist

Quality standard Published: 28 February 2013 nice.org.uk/guidance/qs27

NATIONAL INSTITUTE FOR CLINICAL EXCELLENCE SCOPE

Edited by Colin Hemmings

2017/2018 ADHD Guidelines: A Summary of Recommendations for Pharmacological Treatment From Selected Guidelines

ADHD Training for General Practitioners

North Somerset Autism Strategy

ADHD Guidance September 2013

NICE guideline Published: 14 March 2018 nice.org.uk/guidance/ng87

Week 2: Disorders of Childhood

Audit support for continuous subcutaneous insulin infusion for the treatment of diabetes mellitus (review of technology appraisal guidance 57)

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE. Glaucoma: diagnosis and management of chronic open angle glaucoma and ocular hypertension

ADHD: Real Action, Real Change

THE SCHOOL SETTING INCLUDING THE ROLE OF COMMUNITY CHILD HEALTH MEDICAL AND SCHOOL NURSING SERVICES

Bournemouth, Dorset and Poole Prescribing Forum

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE

Improving Access to Psychological Therapies and care pathways for depression in the UK

Q. As noted in the NICE Quality Standard for ADHD ( can you please provide information on:

Alcohol interventions in secondary and further education

GM ADHD Strategic Clinical Network. Training for Specialist ADHD Teams

Adult ADHD Service Patient Information Leaflet

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE. Type 2 diabetes: the management of type 2 diabetes (update)

Prevalence of Comorbidity and Pattern Drug Use among Children with Attention-deficit hyperactivity disorder: A Single Center in Thailand

National Institute for Health and Clinical Excellence SCOPE. Rheumatoid arthritis: the management and treatment of rheumatoid arthritis in adults

NICE support for commissioning for urinary tract infection in infants, children and young people under 16

NCMH National Centre for Mental Health Attention Deficit Hyperactivity Disorder (ADHD) Information for parents, carers and children

Promoting Excellence: A framework for all health and social services staff working with people with Dementia, their families and carers

King s Research Portal

Correlates of Tic Disorders. Hyperactivity / motor restlessness Inattentiveness Anxiety Aggression Other

Revised Standards. S 1a: The service routinely collects data on age, gender and ethnicity for each person referred for psychological therapy.

Health and Wellbeing Strategy 2016 to 2021 Summary Document

If a specialist asks a GP to prescribe ADHD medication in relation to this disease, the GP should reply to this request as soon as practicable.

A framework for all staff working with people with Autism Spectrum Disorders, their families and carers

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE

Surveillance report Published: 13 April 2017 nice.org.uk. NICE All rights reserved.

ASD and ADHD Pathway. Pride in our children s, young people s and families s e r v i c e s A member of Cambridge University Health Partners

Prescribing framework for Dexamfetamine for Attention Deficit Hyperactive Disorder

NICE Clinical Guidelines recommending Family and Couple Therapy

Pediatric Psychopharmacology

Psychosis with coexisting substance misuse

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE

Curricular Components for General Pediatrics EPA EPA Title Assess and manage patients with common behavior/mental health problems

Challenging Behaviours in Childhood

Behavioural Disorders

Longest running mental health survey series using consistent methods

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE. Proposed Health Technology Appraisal

A guide to Getting an ADHD Assessment as an adult in Scotland

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE

Topic proposal. 1. What is the problem/need for a guideline/clinical scenario?

5 December 2016 Our Ref: RFI Freedom of Information Act 2000 Provision of Services for Attention Deficit Hyperactivity Disorder (ADHD)

ROLE SPECIFICATION FOR MACMILLAN GPs

Adult ADHD. 1. Overview of ADHD 4. Principles for managing ADHD. 2. Common features of ADHD in adults. 3. General approaches to managing ADHD

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:

South East Coast Operational Delivery Network. Critical Care Rehabilitation

Clinical guideline Published: 28 August 2013 nice.org.uk/guidance/cg170

Development method. No Yes No No Yes Yes of children and adolescents. USA Expert consensus on best. validated by independent review

Opinion 3 October 2012

Low back pain and sciatica in over 16s NICE quality standard

Key Issues In Treatment Of Comorbid Bipolar Disorder

The audit is managed by the Royal College of Psychiatrists in partnership with:

Adult Psychiatric Morbidity Survey (APMS) 2014 Part of a national Mental Health Survey Programme

PRACTICE PARAMETERS FOR THE ASSESSMENT AND TREATMENT OF CHILDREN WITH ATTENTION DEFICIT HYPERACTIVITY DISORDER

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE

Transcription:

QS 39 NICE quality standard for attention deficit hyperactivity disorder (QS39) NICE provided the content for this booklet which is independent of any company or product advertised

2 THE COMMISSIONING REVIEW AUTUMN 2013 Introduction In July 2013, NICE published a quality standard for the diagnosis and management of attention in children aged 3 years and older, young people and adults. ADHD is the most common behavioural disorder in the UK, and is estimated to affect 2-5% of school-aged children and young people. By the age of 25, an estimated 15% of people diagnosed with childhood ADHD still have a full range of symptoms, and 65% still have some symptoms that affect their daily lives. ADHD is a behavioural condition characterised by hyperactivity, impulsiveness and inattentiveness. Common symptoms of ADHD include: a short attention span, restlessness or constant fidgeting being easily distracted.

THE COMMISSIONING REVIEW AUTUMN 2013 3 Quality statements Symptoms of ADHD can overlap with symptoms of other related disorders. Common coexisting conditions in children with ADHD include anxiety disorders and disorders of mood, conduct, learning, motor control and social communication; in adults they include personality disorders, bipolar disorder, obsessive compulsive disorder and substance misuse. NICE quality standards describe high-priority areas for quality improvement in a defined care or service area. Each standard consists of a prioritised set of specific, concise and measurable statements. They draw on existing guidance, which provides an underpinning, comprehensive set of recommendations, and are designed to support the measurement of improvement. The quality standard, in conjunction with the guidance on which it is based, should contribute to the improvements outlined in the following frameworks: NHS Outcomes Framework 2013 14 2 Improving outcomes and supporting transparency: Part 1: a public health outcomes framework for England, 2013 2016 3 The Adult Social Care Outcomes Framework, 2013 14 4 The tables following shows the outcomes, overarching indicators and improvement areas from the frameworks that the quality standard could contribute to achieving.

4 THE COMMISSIONING REVIEW AUTUMN 2013 The Adult Social Care Outcomes Framework 2013 14 Domain Enhancing quality of life for people with care and support needs Ensuring that people have a positive experience of care and support Overarching and outcome measures Overarching measure Social care related quality of life* Outcome measures People manage their own support as much as they wish, so that they are in control of what, how and when support is delivered to match their needs. Proportion of people who use services who have control over their daily life. People are able to find employment when they want, maintain a family and social life and contribute to community life, and avoid loneliness or isolation. Proportion of adults in contact with secondary mental health services living independently, with or without support.** Overarching measure People who use social care and their carers are satisfied with their experience of care and support services. Overall satisfaction of people who use services with their care and support. Aligning across the health and care system * Indicator complementary ** Indicator shared Outcome measures People know what choices are available to them locally, what they are entitled to, and who to contact when they need help. The proportion of people who use services and carers who find it easy to find information about support

THE COMMISSIONING REVIEW AUTUMN 2013 5 NHS Outcomes Framework 2013-14 Domain Enhancing quality of life for people with care and support needs Ensuring that people have a positive experience of care and support Overarching and outcome measures Overarching measure Social care related quality of life* Outcome measures People manage their own support as much as they wish, so that they are in control of what, how and when support is delivered to match their needs. Proportion of people who use services who have control over their daily life. People are able to find employment when they want, maintain a family and social life and contribute to community life, and avoid loneliness or isolation. Proportion of adults in contact with secondary mental health services living independently, with or without support.** Overarching measure People who use social care and their carers are satisfied with their experience of care and support services. Overall satisfaction of people who use services with their care and support. Aligning across the health and care system * Indicator complementary ** Indicator shared Outcome measures People know what choices are available to them locally, what they are entitled to, and who to contact when they need help. The proportion of people who use services and carers who find it easy to find information about support.

6 THE COMMISSIONING REVIEW AUTUMN 2013 List of quality statements Statement 1. Children and young people with symptoms of attention are referred to an ADHD specialist for assessment. Statement 2. Adults who present with symptoms of attention deficit hyperactivity disorder (ADHD), who do not have a childhood diagnosis of ADHD, are referred to an ADHD specialist for assessment. Statement 3. Adults who were diagnosed with and treated for attention as children or young people and present with symptoms of continuing ADHD are referred to general adult psychiatric services. Statement 4. Parents or carers of

children with symptoms of attention who meet the NICE eligibility criteria are offered a referral to a parent training programme. Statement 5. Children and young people with moderate attention deficit hyperactivity disorder (ADHD) are offered a referral to a psychological group treatment programme. Statement 6. People with attention who are starting drug treatment have their initial drug dose adjusted and response assessed by an ADHD specialist. Statement 7. People with attention who are taking drug treatment have a specialist review at least annually to assess their need for continued treatment. To implement the quality standard, please refer to the full standard on the NICE website at: http://www.nice.org. uk/qs39 The NICE quality standard for the diagnosis and management of attention in children aged 3 years and older, young people and adults is based on the following NICE guidance: National Institute for Health and Clinical Excellence (2013) Antisocial behaviour and conduct disorders in children and young people: recognition, intervention and management. NICE clinical guideline 158. http://guidance.nice.org.uk/cg158 National Institute for Health and Clinical Excellence (2009) Attention deficit hyperactivity disorder: diagnosis and management of ADHD in children, young people and adults. NICE clinical guideline 72. http:// guidance.nice.org.uk/cg72 National Institute for Health and Clinical Excellence (2006) Attention - methylphenidate, atomoxetine and dexamfetamine (review). NICE technology appraisal guidance 98. http://guidance.nice.org.uk/ta98 References 1. NHS Choices - www.nhs.uk/conditions/ Attention-deficit-hyperactivity-disorder/Pages/ Introduction.aspx 2. NHS Outcomes Framework 2013 14 - www. gov.uk/government/publications/nhs-outcomesframework-2013-to-2014 3. Improving outcomes and supporting transparency: Part 1: a public health outcomes framework for England, 2013-2016 - www.dh.gov.uk/ en/publicationsandstatistics/publications/ PublicationsPolicyAndGuidance/DH_132358 4. The Adult Social Care Outcomes Framework, 2013 14 - www.dh.gov.uk/health/2012/11/ ascof1314/